期刊文献+

异基因骨髓间充质干细胞逆向嵌合体诱导小鼠皮肤移植耐受研究

Allogenic BMSCs Reverse Chimerism Inducing the Tolerance of Xeno-skin Graft in Mouse Model
原文传递
导出
摘要 目的探讨骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMSCs)诱导移植免疫耐受的可行性,建立小鼠异种逆向嵌合皮肤移植模型。方法以GFP-C57BL/10雄鼠为BMSCs供者,选择免疫缺陷型BALB/C-nu/nu雌鼠为BMSCs受者,移植BMSCs,建立骨髓嵌合模型;通过RT-PCR检测Y染色体性别决定区基因(SRY)、免疫组化检测GFP蛋白表达量,确定嵌合产生的最佳时间。实验共分3组:将接受BMSCs移植一定时间后的BALB/C-nu/nu雌鼠的皮肤移植给C57BL/10雄鼠(实验组),将未接受BMSCs移植的BALB/C-nu/nu雌鼠的皮肤移植给C57BL/10雄鼠(排斥组),C57BL/10小鼠间进行同种异体皮肤移植(对照组)。观察移植皮肤存活情况,检测存活皮肤的血管形成情况,以此探讨逆向嵌合皮肤移植的可行性。结果成功建立骨髓嵌合模型,用1×106 BMSCs移植后4周,SRY基因和GFP蛋白的表达量最高,分别为1.22±0.10、458.0±3.4,与移植后1周、2周和6周比较差异均有统计学意义(P<0.05),说明嵌合产生的最佳时间为移植后4周。实验组小鼠供者来源皮肤移植物存活>14d,排斥组平均为5d。结论 BMSCs移植后可形成嵌合体,并可逆向嵌合移植诱导异种小鼠皮肤移植耐受。 Objective To investigate the feasibility of bone marrow mesenchymal stem cells (BMSCs) in inducing immune tolerance and to establish the mouse model of reverse chimerism in xeno-skin transplantation. Methods The mouse model of bone marrow-chimerism was established with immuncompromised BAI.B/C-nu/nu female mice by receiving the transplantation of BMSCs from green fluorescent protein (GFP)-C57BL/10 male mice, the optimized chimeric time was identified by RT-PCR testing of SRY gene and immunohistochemistry measurement of GFP expression. In the experiment group, GFP-C57BL/10 male mice received the transplantation of the skin from immuncompromised BALB/C-nu/nu female mice with BMSCs bone marrow chimerism. In the rejection group, GFP-C57BL/10 male mice received the transplantation of the skin from immuncompromised BALB/C-nu/nu female mice without BMSCs bone marrow-chimerism. In the control group, allo-transplantation of skin was performed in GFP-C57BL/10 male mice. Histological study was performed to investigate the survival rate and angiogenesis of the transplanted skin. Results The bone marrow chimeric model was established, the expressions of SRY gene and GFP protein reached the highest level at four weeks (1.22 ± 0. 10 458.0± 3.4) post-transplanted with BMSCs (106), which was significantly different in comparison with those at one week, two weeks and six weeks post- transplantation(P〈0.05). Four-weeks after transplantation was further confirmed as the optimized chimeric time. The mean survival time of donor skin graft 〉 14 d in the experimental group, while it only was 5 d in the rejection group. Conclusion The bone marrow-chimerism can be formed in the recipient by donor BMSCs transplantation, which can further induce tolerance of mice xeno-skin transplantation by reverse chimerism.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2013年第2期165-169,共5页 Journal of Sichuan University(Medical Sciences)
基金 教育部-博士点基金(No.20060610060)资助
关键词 GFP小鼠 骨髓 干细胞移植 嵌合体 皮肤移植耐受 GFP mice Bone marrow Stem cell transplantation Chimerism Skin grafttolerance
  • 相关文献

参考文献15

  • 1Oluwole SF, Oluwole OO, Adeyeri AO, el al. New strategies in immune tolerance induction. Cell Biochem Biophys, 2004 ; 40 (3 Suppl) :27- 48.
  • 2Van der Meulen J, Mi/sud NA, Abud D, et al. Di/ferentia] dynamics of donor DC and nomDC peripheral blood mononuclear cell microchimerism in lung transplantation. Clin Immunol, 2009 ; 133(2) : 179-183.
  • 3Baurmann H, Nagel S, Binder T, et al. Kinetics of lhe graft versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood, 1998 , 92 (10): 3582-3590.
  • 4张文元,杨亚冬,房国坚,陈勇.抗淋巴细胞血清联合脾细胞促进异基因骨髓细胞形成嵌合体诱导免疫耐受[J].现代医药卫生,2008,24(3):319-320. 被引量:2
  • 5Elwood ET, Larsen CP, Maurer DH, et al. Microchimerism and rejection in clinical transplantation. Lancet, 1997; 349 (9062):1358 -1360.
  • 6ZhangW, Ge W, l.i C, et al. Effects of mesenchymal steam cells on differentiation, maturation, and function of human monocyte derived dendritic cells. Steam Cells, 2004, 13 ( 3 ) : 263 -271.
  • 7Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res, 200,5 ,305 (1) :33-41.
  • 8MeiselR, Zibert A, Laryea M, et al. Human bone marrow stroma! cells inhibit allogeneic Tcell responses by /ndoleamine 2, 3 dioxygenase mediated tryptophan degradation. Blood, 2004;103(12):4619-4621.
  • 9Mackenzie TC, Flake AW. Human mesenchymal stem ceils persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Ceils Mol Dis,2001;27(3) :601 -604.
  • 10Krause DS, Theise ND, ColLector MI, et al. Multiorgan, muhi-lineage engraftment by a sing]e bone marrow-derived stem cell. Cell,2001 ;105(3) :369r377.

二级参考文献26

  • 1都义日,付小兵,李存保.骨髓间充质干细胞的研究进展[J].中国危重病急救医学,2004,16(8):499-501. 被引量:13
  • 2谢燕丹,刘元生.骨髓间充质干细胞在骨髓移植中的应用[J].广西医学,2007,29(2):216-218. 被引量:2
  • 3Le Blanc K, Ringden O.Immunomodulation by mesenchymal stem cells and clinical experience[J].J Intern Med,2007,262(5):509-525.
  • 4S Glennie,I Soeiro,PJ Dyson,et al.Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells[J].Blood,2005,102(38): 2821-2827.
  • 5Conclaves MA,DE Varies AA.Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion [J].Hum Mol Genet,2006,15 (2): 213-221.
  • 6Sadaki A,Shin I, Kevin F,et al.Mesenchymal stem cells suppress B2 cell terminal differentiation [J].Experimental Hematology,2009,58(37):604.
  • 7Gothelrstrom C,Ringden O,Tammik C,et al.Immunologic properties of human fetal mesenchymal stem cells[J].Am J Obstet Gynecol,2001,190 (1):239-245.
  • 8Djouad F,Plence P,Bony C,et al.lmmunosuppressive dffect of messenchymal stem cells favors tumor growth in allogeneic animals[J].Blood, 2003,25(10):102.
  • 9Inoue S,Popp FC,Koehl GE et al.Immunnomodulatory effectss of mesenchymal stem cells in a rat organ transplant model[J].Transplantation, 2006,81(11):1589-1595.
  • 10Deans RJ,Moseley AB.Mesenchymal stem cells:Biology and potential clinical uses[J].Exp Hematol,2000,33(28):875-884.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部